Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Sunrise |
| Country | Belgium |
| Start Date | Jul 01, 2022 |
| End Date | Dec 31, 2024 |
| Duration | 914 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190180051 |
Sunrise is a leading researcher and developer of solutions for diagnosis and treatment of sleep apnea.
Our goal is to develop and commercialise Sunrise Tx, the first truly non-invasive, affordable and readily accessible solution to treat sleep apnea.
This is to address the 80% treatment gap of sleep apnea sufferers who fail to access treatment due to high costs and long waiting times for diagnosis.
Also, even within those diagnosed, at least 35% fail to comply with wearing a mask all night strapped tightly to the face, blowing air to clear airways for breathing due to the associated discomfort. In contrast Sunrise Tx is a wearable device involving no nasal obstruction. Sunrise Tx is set to improve treatment access, compliance, cost and accuracy.
Sunrise
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant